Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Feb 4, 2026
Reporting period
Not applicable
Filed with the SEC
Feb 5, 2026
CEOIndirect holdingOther
Context
Classification
other
Code J — not an open-market trade
Planned / mechanical clue
None found in footnotes
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001193125-26-039805
Filed / recorded
Feb 5, 2026, 11:33 PM UTC
Added to OQRO
Oct 2, 2026, 12:28 PM UTC
Parser
form4-xml-v1
Data quality
Verified: identifiers matched exactly
Issuer
HCA Healthcare, Inc.
Issuer CIK
860730
Ticker
HCA
Reporting person
Samuel N Hazen
Relationship
Director, Officer
Officer title
CEO
Security
Common Stock
Table
Non-derivative (Table I)
Transaction date
Feb 4, 2026
Transaction code
J
Shares / units
1,045
Price per share
$498.35
Acquired / disposed
Acquired (A)
Shares owned after
16,024
Ownership form
Indirect — By HD Trust
Amendment
No
Footnotes from the filing
Pursuant to a power of substitution, on February 4, 2026, the Reporting Person transferred 1,045 shares of common stock of the Issuer to a trust in exchange for assets of equal value. The transfer was made at a price per share equal to $498.35 (the average of the high and low prices of shares of common stock of the Issuer on February 4, 2026). The transfer did not change the total number of shares of common stock of the Issuer of which the Reporting Person may be deemed to have beneficial ownership. The Reporting Person believes that the transfer of shares to the trust constitutes a change in form of beneficial ownership of such shares, exempted by Rule 16a-13 under the Securities Exchange Act of 1934.
